Cited by 111AI in cancer detectionGenetic factors in colorectal cancerArtificial Intelligence in Healthcare and Education

Artificial intelligence for detection of microsatellite instability in colorectal cancer—a multicentric analysis of a pre-screening tool for clinical application

Open access
Echle, A., Ghaffari Laleh, N., Quirke, P., Grabsch, H.I., Muti, H.S., Saldanha, O.L., Brockmoeller, S.F., van den Brandt, P.A. +30 more·2022·ESMO Open

Abstract

BACKGROUND: Microsatellite instability (MSI)/mismatch repair deficiency (dMMR) is a key genetic feature which should be tested in every patient with colorectal cancer (CRC) according to medical guidelines. Artificial intelligence (AI) methods can detect MSI/dMMR directly in routine pathology slides, but the test performance has not been systematically investigated with predefined test thresholds. METHOD: We trained and validated AI-based MSI/dMMR detectors and evaluated predefined performance metrics using nine patient cohorts of 8343 patients across different countries and ethnicities. RESULTS: Classifiers achieved clinical-grade performance, yielding an area under the receiver operating curve (AUROC) of up to 0.96 without using any manual annotations. Subsequently, we show that the AI system can be applied as a rule-out test: by using cohort-specific thresholds, on average 52.73% of tumors in each surgical cohort [total number of MSI/dMMR = 1020, microsatellite stable (MSS)/ proficient mismatch repair (pMMR) = 7323 patients] could be identified as MSS/pMMR with a fixed sensitivity at 95%. In an additional cohort of N = 1530 (MSI/dMMR = 211, MSS/pMMR = 1319) endoscopy biopsy samples, the system achieved an AUROC of 0.89, and the cohort-specific threshold ruled out 44.12% of tumors with a fixed sensitivity at 95%. As a more robust alternative to cohort-specific thresholds, we showed that with a fixed threshold of 0.25 for all the cohorts, we can rule-out 25.51% in surgical specimens and 6.10% in biopsies. INTERPRETATION: When applied in a clinical setting, this means that the AI system can rule out MSI/dMMR in a quarter (with global thresholds) or half of all CRC patients (with local fine-tuning), thereby reducing cost and turnaround time for molecular profiling.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.esmoop.2022.100400

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A line of work has focused on developing and validating AI for predicting microsatellite instability, a feature associated with clinical outcomes and a biomarker for immunotherapy.

    “a line of work (97-99) has focused on developing and validating AI for predicting microsatellite instability (MSI), a feature associated with clinical outcomes and a biomarker for immunotherapy (100).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [11]Schirris Y, Gavves E, Nederlof I, Horlings HM, Teuwen J. DeepSMILE: Self-supervised heterogeneity-aware multiple instance learning for DNA damage response defect classification directly from H&E whole-slide images. arXiv [eess.IV] 2021.

Cited by

Sorted by citations

Authors
Echle, A., Ghaffari Laleh, N., Quirke, P., Grabsch, H. I., Muti, H. S., Saldanha, O. L., Brockmoeller, S. F., van den Brandt, P. A., Hutchins, G. G. A., Richman, S. D., Horisberger, K., Galata, C., Ebert, M. P., Eckardt, M., Boutros, M., Horst, D., Reissfelder, C., Alwers, E., Brinker, T. J., Langer, R., Jenniskens, J. C. A., Offermans, K., Mueller, W., Gray, R., Gruber, S. B., Greenson, J. K., Rennert, G., Bonner, J. D., Schmolze, D., Chang-Claude, J., Brenner, H., Trautwein, C., Boor, P., Jaeger, D., Gaisa, N. T., Hoffmeister, M., West, N. P., & Kather, J. N.
Affiliations
  • Universitätsklinikum Aachen (DE)
  • University of Leeds (GB)
  • University Hospital Zurich (CH)
  • Johannes Gutenberg University Mainz (DE)
  • Heidelberg University (DE)
  • German Cancer Research Center (DE)
  • Charité – Universitätsmedizin Berlin (DE)
  • University of Bern (CH)
  • Maastricht University Medical Centre (NL)
  • University of Oxford (GB)
  • City Of Hope National Medical Center (US)
  • Technion – Israel Institute of Technology (IL)
  • Universität Hamburg (DE)
  • University Hospital Heidelberg (DE)
Corresponding author
Kather, J.N.
Venue
ESMO Open
Publisher
Elsevier BV
Published
2022-04
Volume
7
Issue
2
Pages
100400
ISSN
2059-7029 (ISSN-L)
OpenAlex
W4214909253
Cited by
111
References
37
Citations by year
2026: 12 · 2025: 25 · 2024: 30 · 2023: 28 · 2022: 16
FWCI
8.14
Type
journal article
Language
en
Open access
Locations
  • ESMO Open (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • BORIS (University Library Bern) (submittedVersion, cc-by)
  • RWTH Publications (RWTH Aachen) (submittedVersion, other-oa)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • RWTH Publications (RWTH Aachen)
  • Open Access CRIS of the University of Bern
Funders
  • Bundesministerium für Bildung und Forschung (STOP-FSGS01GM1901A)
  • Bundesministerium für Gesundheit (ZMVI1-2520DAT111)
  • Bundesministerium für Bildung Wissenschaft Forschung und Technologie Dienststelle Berlin
  • National Institute for Health and Care Research
  • Deutsche Forschungsgemeinschaft (SFB-CRC1382)
  • National Institutes of Health (R01 CA197350)
  • Yorkshire Cancer Research (L386)
  • Bundesministerium für Wirtschaft und Energie (R01 CA81488)
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Keywords
microsatellite instability, mismatch repair deficiency, colorectal cancer, artificial intelligence, computer-aided diagnosis, histopathology image analysis, rule-out test, prescreening, surgical specimens, molecular profiling, fine-tuning
MeSH terms
Artificial Intelligence, Humans, Colorectal Neoplasms, Microsatellite Instability, DNA Mismatch Repair, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review